FOXO Behavioral Health Subsidiary Approved for Scott County Opioid Funds

WEST PALM BEACH, FLORIDA, June 30, 2025

FOXO Technologies Inc. (NYSE American: FOXO) today announced a significant development for its behavioral health subsidiary, Myrtle Recovery Centers, Inc. The company has secured a second year of funding from Scott County for its crucial opioid abatement program. This renewed support, commencing July 1, 2025, will enable Myrtle Recovery Centers to continue providing essential care to uninsured patients from Scott County at its facility in Oneida, Tennessee.

“We are incredibly grateful for Scott County’s continued commitment to addressing the opioid crisis and supporting those in need,” said Robert Merritt, Chief Executive Officer of Myrtle. “Securing this funding for a second consecutive year, particularly as our facility is operating at full capacity with a waiting list, is a true testament to the caliber of care our clinical team delivers. We are eager to further expand our reach and extend our proven clinical programs to a broader patient base.”

Seamus Lagan, CEO of parent company FOXO Technologies Inc., echoed this sentiment, highlighting Myrtle’s growing impact. “Myrtle’s rapid operational ramp-up and substantial positive influence within the rural communities it serves are truly encouraging. We envision significant growth for Myrtle through a combination of organic expansion and strategic acquisitions, positioning this subsidiary as a key contributor to FOXO’s revenue and long-term value. As we close out the first half of the year, we are filled with anticipation for the remainder of 2025, and we look forward to showcasing our advancements from the second quarter in our upcoming report.”

About FOXO Technologies Inc. (“FOXO”)

FOXO Technologies Inc. is a diversified healthcare company with a portfolio of three distinct subsidiaries:

• Rennova Community Health, Inc. operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical), a critical access designated hospital in East Tennessee, dedicated to providing vital healthcare services to its community.
• Myrtle Recovery Centers, Inc. is a 30-bed behavioral health facility situated in East Tennessee. It offers comprehensive inpatient services for detox and residential treatment, alongside robust outpatient programs, including Medication-Assisted Treatment (MAT) and Opioid Use Disorder (OUD) treatment.
• FOXO Labs, Inc. is at the forefront of biotechnology, committed to enhancing human health and longevity through the development of innovative technology and product solutions across various industries.

For more information about FOXO, please visit www.foxotechnologies.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements, which are not historical in nature, reflect FOXO’s current beliefs and expectations regarding future events. However, forward-looking statements are subject to inherent risks and uncertainties, and actual results may differ materially. Factors that could cause such differences include, but are not limited to, changes in the competitive and highly regulated industries in which FOXO operates, variations in operating performance among competitors, alterations in laws and regulations affecting FOXO’s business, the successful implementation of FOXO’s business plans and forecasts, the ability to secure financing, the historical track record of losses and the potential to achieve future profitability, the ability to establish and maintain necessary relationships to advance its goals, the enforceability of FOXO’s intellectual property rights, and potential downturns and evolving regulatory landscapes in the biotechnology and broader market sectors. This list of factors is not exhaustive. Readers are advised to carefully consider these factors and other risks and uncertainties detailed in FOXO’s filings with the SEC, including its most recent Forms 10-K and 10-Q, particularly within the “Risk Factors” sections. These filings identify and discuss other significant risks that could lead to material differences between actual events and results and those projected in the forward-looking statements. Forward-looking statements are made as of the date of this release, and FOXO undertakes no obligation to update or revise them, whether due to new information, future events, or any other reason.